Cargando…
Dramatic Response After Switching MEK Inhibitors in a Patient With Refractory Mixed Histiocytosis
We report the case of a patient with progressive multisystem mixed histiocytosis associating Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) involving the bone marrow, whose lesions harbored the MAP2K1 E102-I103del. After initial improvement under the MEK inhibitor trametinib,...
Autores principales: | Roeser, Anais, Jouenne, Fanelie, Vercellino, Laetitia, Calvani, Julien, Goldwirt, Lauriane, Lorillon, Gwenael, Tazi, Abdellatif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635797/ https://www.ncbi.nlm.nih.gov/pubmed/36406830 http://dx.doi.org/10.14740/jh1030 |
Ejemplares similares
-
How I manage pulmonary Langerhans cell histiocytosis
por: Lorillon, Gwenaël, et al.
Publicado: (2017) -
Management and outcomes of pneumothorax in adult patients with Langerhans cell Histiocytosis
por: Le Guen, Pierre, et al.
Publicado: (2019) -
Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis
por: Jouenne, Fanélie, et al.
Publicado: (2020) -
Extrathoracic investigation in adult patients with isolated pulmonary langerhans cell histiocytosis
por: Tazi, Abdellatif, et al.
Publicado: (2016) -
Psychological features of adult patients with langerhans cell histiocytosis
por: Bugnet, Emmanuelle, et al.
Publicado: (2021)